Butein, a novel dual inhibitor of MET and EGFR, overcomes gefitinib-resistant lung cancer growth. Jung, S. K., Lee, M., Lim, D. Y., Lee, S. Y., Jeong, C., Kim, J. E., Lim, T. G., Chen, H., Bode, A. M, Lee, H. J., & others Molecular carcinogenesis, 54(4):322–331, 2015.
bibtex   
@article{jung2015butein,
  title={Butein, a novel dual inhibitor of MET and EGFR, overcomes gefitinib-resistant lung cancer growth},
  author={Jung, Sung Keun and Lee, Mee-Hyun and Lim, Do Young and Lee, Sung Young and Jeong, Chul-Ho and Kim, Jong Eun and Lim, Tae Gyu and Chen, Hanyong and Bode, Ann M and Lee, Hyong Joo and others},
  journal={Molecular carcinogenesis},
  volume={54},
  number={4},
  pages={322--331},
  year={2015}
}

Downloads: 0